Eros International PLC NYSE Listing & Cancellation of Admission to AIM (9545S)
13 November 2013 - 4:06PM
UK Regulatory
TIDMEROS
RNS Number : 9545S
Eros International PLC
13 November 2013
Eros International Plc ("Eros" or the "Company")
13(th) November 2013
NYSE Listing and Cancellation of Admission to AIM
Eros confirms that the Company's NYSE listing has become
effective today and the cancellation of the Company's admission to
AIM is expected to take place at 7.00 a.m. tomorrow, 14(th)
November 2013.
For further information, please contact:
Andrew Heffernan
Chief Financial Officer
Eros International Plc
Eros International Plc
Sean Hanafin
Chief Corporate & Strategy Officer
T: +44 (0)20 7258 9909
Jamie M.M. Kirkwood
VP, Investor Relations
T: +44 (0)20 7258 9906
Investec Bank plc
Nominated Adviser & Joint Broker
Jeremy Ellis / Carlton Nelson / Patrick Robb
T: +44 (0) 20 7597 5000
Peel Hunt LLP
Joint broker
Richard Kauffer / Dan Harris / Andy Crossley
T: +44 (0) 20 7418 8900
About Eros International Plc
-- Eros co-produces, acquires and distributes Indian language
films, in multiple formats worldwide
-- In 2006, Eros listed its shares on the AIM Market of the London Stock Exchange
-- In October 2010, Eros listed its Indian subsidiary Eros
International Media on the BSE & NSE in India
-- Eros operates in over 50 countries, with offices throughout
India, the United Kingdom, USA, UAE, Singapore, Australia, Fiji and
the Isle of Man
A registration statement and post-effective amendment relating
to the Company's A ordinary shares has been filed with and declared
effective by the United States Securities and Exchange Commission.
This document shall not constitute an offer to sell or a
solicitation of an offer to buy nor shall there be any offer or
sale of these securities in any state or jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of such state or
jurisdiction.
Some of the information presented in this press release and in
related comments by the Company's management contains
forward-looking statements. In some cases, these forward-looking
statements are identified by terms and phrases such as "aim,"
"anticipate," "believe," "feel," "contemplate," "intend,"
"estimate," "expect," "continue," "should," "could," "may," "plan,"
"project," "predict," "will," "future, " "goal," "objective," and
similar expressions and include references to assumptions and
relate to the Company's future prospects, developments and business
strategies. Similarly, statements that describe the Company's
strategies, objectives, plans or goals and statements regarding the
proposed offering and the anticipated costs of these transactions
are forward-looking statements and are based on information
available to the Company as of the date of this press release.
Forward-looking statements are subject to risks, uncertainties and
assumptions that could cause actual results to differ materially
from those contemplated by the relevant statement. Such risks and
uncertainties include a variety of factors, some of which are
beyond the Company's control. In particular, such risks and
uncertainties include market conditions. Information concerning
these and other factors that could cause results to differ
materially from those contained in the forward-looking statements
is contained under the caption "Risk Factors" in the Company's
Registration Statement on Form F-1 filed with the U.S. Securities
and Exchange Commission. The Company undertakes no obligation to
revise the forward-looking statements included in herein to reflect
any future events or circumstances, except as required by law. The
Company's actual results, performance or achievements could differ
materially from the results expressed in, or implied by, these
forward-looking statements.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEXLFFXFFBFBL
Eros (LSE:EROS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Eros (LSE:EROS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024